首页 > 市场调查报告书 > 医疗设备

透析机设备

连续性肾臟替代疗法（CRRT）市场规模、份额和成长分析（按治疗方法、最终用户、年龄层和地区划分）—2026-2033年产业预测

市场调查报告书

商品编码

1897216

连续性肾臟替代疗法（CRRT）市场规模、份额和成长分析（按治疗方法、最终用户、年龄层和地区划分）—2026-2033年产业预测

Continuous Renal Replacement Therapy Market Size, Share, and Growth Analysis, By Modality, By End User, By Age Group, By Region -Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，连续性肾臟替代疗法 (CRRT) 市场规模将达到 15.1 亿美元，到 2025 年将达到 16.3 亿美元，到 2033 年将达到 30.4 亿美元，在预测期（2026-2033 年）内，复合年增长率为 8.1%。

肾臟疾病和急性肾损伤盛行率的上升预计将显着推动对连续性肾臟替代疗法（CRRT）的需求。人口老化以及老年人肾功能障碍风险的增加，预计将推动CRRT解决方案市场的发展。此外，严重肾臟疾病患者数量的增加以及CRRT技术的进步也创造了新的成长机会。新兴市场医疗费用支出的成长以及人们对创新肾臟疗法日益增长的兴趣，有望提升CRRT服务提供者的收入前景。然而，高昂的治疗费用、潜在的併发症、熟练专业人员的短缺以及严格的监管要求等挑战，可能会在未来阻碍CRRT的广泛应用。

全球连续性肾臟替代疗法 (CRRT) 市场按产品、治疗方法、年龄层、最终用户和地区进行细分。依产品划分，CRRT 市场分为透析液和替代液、一次性耗材以及 CRRT 系统。依治疗方法划分，CRRT 市场分为连续性静脉-静脉血液滤过 (CVVHF)、连续性静脉-静脉血液透析滤过 (CVHDF)、连续性静脉-静脉血液透析 (CVHD) 和慢速超过滤(SCUF)。依年龄组别划分，CRRT 市场分为成人、儿童和新生儿。按最终用户划分，CRRT 市场分为医院、门诊诊所、居家医疗和其他最终用户。按地区划分，CRRT 市场分为北美、欧洲、亚太地区、中东和非洲以及拉丁美洲。

连续性肾臟替代疗法市场驱动因素

全球连续性肾臟替代疗法 (CRRT) 市场的主要驱动因素之一是慢性肾臟病(CKD) 和急性肾损伤 (AKI) 在全球人群中的盛行率不断上升。糖尿病、高血压和心血管疾病等文明病的增加，显着提高了对有效肾臟替代疗法的需求。此外，人口老化推动了对先进医疗技术的需求，进一步促进了 CRRT 的应用。同时，CRRT 设备的技术进步正在改善患者预后并提高医疗机构的营运效率，进一步推动市场成长，使这些治疗方法成为重症监护管理的重要组成部分。

限制连续性肾臟替代疗法市场的因素

全球连续性肾臟替代疗法（CRRT）市场的主要限制因素之一是CRRT设备的购买和维护成本高。预算限制使得许多医疗机构，尤其是发展中地区的医疗机构，难以对先进的透析技术进行投资。儘管CRRT在治疗急性肾损伤方面具有许多益处，但此经济障碍可能会阻碍其广泛应用。此外，CRRT操作流程复杂，需要医护人员接受专门培训，这可能导致医疗机构难以分配有效实施和运作所需的资源，从而进一步加剧了市场挑战。

连续性肾臟替代疗法（CRRT）市场趋势

在连续性肾臟替代疗法（CRRT）市场，人工智慧（AI）的融合应用已成为提升治疗效果和改善患者预后的显着趋势。医疗机构正加速采用AI驱动的解决方案，以实现即时患者监测、併发症预测分析以及基于个别患者需求的个人化治疗。此举旨在简化治疗流程，并提升CRRT患者照护水准。随着医疗保健产业日益拥抱技术创新，AI的整合应用有望彻底革新临床实践，并推动CRRT领域的成长和创新。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲（MEA）
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争格局

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市集活动
主要企业市占率（2025 年）

主要企业简介

Baxter International, Inc.（US）
Fresenius Medical Care AG & Co. KGaA（Germany）
Nikkiso Co., Ltd.（Japan）
B. Braun Melsungen AG（Germany）
Medtronic PLC（Ireland）
Asahi Kasei Corporation（Japan）
Toray Medical Co., Ltd.（Japan）
Nipro Corporation（Japan）
Infomed SA（Switzerland）
Medica SPA（Italy）
Medites Pharma Spol. SRO（Czech Republic）
Medical Components, Inc.（US）
SWS Hemodialysis Care Co., Ltd.（China）
Ningbo Tianyi Medical Devices Co., Ltd.（China）
Anjue Medical Equipment Co., Ltd.（China）
Kimal（UK）
Jiangxi Sanxin Medtech Co., Ltd.（China）
Allmed Medical Products Co., Ltd.（China）
Dialco Medical Inc.（US）
Browndove Healthcare Pvt. Ltd.（India）
Steris PLC（US）
Kuraray Medical PLC（Japan）
Livanova PLC（UK）
Diaverum Deutschland GmbH（Germany）
Sembcorp Industries（Singapore）

简介目录

Product Code: SQMIG35A2403

Continuous Renal Replacement Therapy Market size was valued at USD 1.51 Billion in 2024 and is poised to grow from USD 1.63 Billion in 2025 to USD 3.04 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The rising prevalence of kidney disorders and acute kidney injuries is set to significantly drive the demand for continuous renal replacement therapy (CRRT). An aging population, coupled with an increased risk of kidney dysfunction among older adults, is anticipated to boost the market for CRRT solutions. Additionally, the growing number of patients with severe kidney conditions and technological advancements in CRRT present new opportunities for expansion. Increased healthcare spending in emerging markets and a rising interest in innovative kidney treatments are likely to enhance revenue prospects for CRRT providers. However, challenges such as high treatment costs, potential complications, a shortage of skilled professionals, and strict regulatory requirements may hinder broader adoption of CRRT in the future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Continuous Renal Replacement Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Continuous Renal Replacement Therapy Market Segments Analysis

Global Continuous Renal Replacement Therapy Market is segmented on the product, modality, age group, end user, and region. By product, market is segmented into dialysate & replacement fluids, disposables, and CRRT Systems. By modality, market is segmented into continuous venovenous hemofiltration, continuous venovenous hemodiafiltration, continuous venovenous hemodialysis, and slow continuous ultrafiltration. By age group, market is segmented into adults, and pediatrics & neonates. By end user, market is segmented into hospitals, ambulatory care, home care, and other end users. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Continuous Renal Replacement Therapy Market

One of the key market drivers for the Global Continuous Renal Replacement Therapy (CRRT) market is the increasing prevalence of chronic kidney diseases (CKD) and acute kidney injury (AKI) among the global population. As lifestyle diseases, diabetes, hypertension, and cardiovascular conditions escalate, the need for effective renal replacement therapies grows significantly. Additionally, the rising aging population demands advanced medical technologies, further propelling the adoption of CRRT. Moreover, technological advancements in CRRT devices that enhance patient outcomes and improve operational efficiencies in healthcare settings are also driving market growth, making these therapies essential components in critical care management.

Restraints in the Continuous Renal Replacement Therapy Market

One significant market restraint for the global Continuous Renal Replacement Therapy (CRRT) market is the high cost associated with the procurement and maintenance of CRRT equipment. Many healthcare facilities, especially in developing regions, face budget constraints that limit their ability to invest in advanced dialysis technologies. This financial barrier can hinder the widespread adoption of CRRT, despite its benefits in managing acute kidney injury. Additionally, the complexity of CRRT procedures requires specialized training for healthcare providers, which further contributes to the market's challenges as facilities may struggle to allocate the necessary resources for effective implementation and operation.

Market Trends of the Continuous Renal Replacement Therapy Market

The Continuous Renal Replacement Therapy (CRRT) market is witnessing a notable trend towards the integration of artificial intelligence (AI) to enhance treatment efficacy and patient outcomes. Providers are increasingly adopting AI-driven solutions that enable real-time monitoring of patients, predictive analytics for potential complications, and the personalization of therapy based on individual patient needs. This shift not only aims to optimize the efficiency of treatment procedures but also seeks to improve overall patient care standards within CRRT. As healthcare increasingly embraces technological advancements, the incorporation of AI is set to revolutionize practices, driving growth and innovation within the CRRT sector.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Patent Analysis
Trade Analysis
Technology Analysis
Value Chain Analysis
Customer & Buying Criteria Analysis

Continuous Renal Replacement Therapy Market, By Product

Market Overview
Dialysate & Replacement Fluids
Disposables
- Hemofilters
- Bloodline Sets & Tubes
- Other Disposables
CRRT Systems

Continuous Renal Replacement Therapy Market, By Modality

Market Overview
Continuous Venovenous Hemofiltration
Continuous Venovenous Hemodiafiltration
Continuous Venovenous Hemodialysis
Slow Continuous Ultrafiltration

Continuous Renal Replacement Therapy Market, By Age Group

Market Overview
Adults
Pediatrics & Neonates

Continuous Renal Replacement Therapy Market, By End User

Market Overview
Hospitals
Ambulatory Care
Home Care
Other End Users

Continuous Renal Replacement Therapy Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Baxter International, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Medical Care AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nikkiso Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asahi Kasei Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Toray Medical Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Infomed SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medica SPA (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medites Pharma Spol. S.R.O. (Czech Republic)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medical Components, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SWS Hemodialysis Care Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ningbo Tianyi Medical Devices Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anjue Medical Equipment Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kimal (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jiangxi Sanxin Medtech Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allmed Medical Products Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dialco Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Browndove Healthcare Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Steris PLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kuraray Medical PLC (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Livanova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diaverum Deutschland GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sembcorp Industries (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments